Subscribe
handing-over-100-dollar-bills
21 March 2018Americas

J&J plans to sell LifeScan for $2.1bn

Johnson & Johnson (J&J) has revealed plans to sell LifeScan, its blood glucose monitoring unit, for $2.1 billion.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
J&J to boost medical device division with acquisition
22 February 2018   Johnson & Johnson has revealed plans to strengthen its medical device capabilities with the acquisition of French medical technology company Orthotaxy.
Europe
J&J to acquire maker of 3D-printed spinal implants
14 September 2018   Johnson & Johnson announced this week that its subsidiary J&J Medical has acquired Emerging Implant Technologies (EIT) for an undisclosed amount.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

More on this story

Big Pharma
J&J to boost medical device division with acquisition
22 February 2018   Johnson & Johnson has revealed plans to strengthen its medical device capabilities with the acquisition of French medical technology company Orthotaxy.
Europe
J&J to acquire maker of 3D-printed spinal implants
14 September 2018   Johnson & Johnson announced this week that its subsidiary J&J Medical has acquired Emerging Implant Technologies (EIT) for an undisclosed amount.

More on this story

Big Pharma
J&J to boost medical device division with acquisition
22 February 2018   Johnson & Johnson has revealed plans to strengthen its medical device capabilities with the acquisition of French medical technology company Orthotaxy.
Europe
J&J to acquire maker of 3D-printed spinal implants
14 September 2018   Johnson & Johnson announced this week that its subsidiary J&J Medical has acquired Emerging Implant Technologies (EIT) for an undisclosed amount.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility